Jeanette Erdmann is a new member of the National Academy of Sciences Leopoldina

The National Academy of Sciences Leopoldina unites researchers with special expertise in their respective fields. The criterion for admission is outstanding scientific achievement.

Among scientists, admission to the ranks of Leopoldina members is considered one of the highest honours – Prof. Jeanette Erdmann has received it. The biologist is the only professor at the University of Lübeck who is currently a member of the National Academy of Sciences Leopoldina.

Her path into the world of research led Jeanette Erdmann to the Institute of Human Genetics in Bonn after completing her studies at the University of Cologne, where she wrote her doctoral thesis. After her doctorate, she worked as a research group leader in Berlin and Regensburg. Jeanette Erdmann completed her habilitation at the University of Regensburg. She has worked at the University of Lübeck since 2003.

In 2012 she was appointed W3 Professor for Life in Lübeck and subsequently DZHK Professor by the German Centre for Cardiovascular Research. Since 2013, she has successfully led the newly founded Institute of Cardiogenetics, which aims to better understand the genetic factors that lead to cardiovascular diseases, e.g. atherosclerosis and heart attacks, in order to develop new therapies. “Since the beginning of my PhD, I have been working on the inheritance of common, so-called complex diseases, first with schizophrenia and depression and for 15 years now with cardiovascular diseases. For a few years now, however, I have expanded my field of research and we are currently also developing a therapy for a rare neuromuscular disease that I diagnosed myself with a few years ago,” reports Prof. Jeanette Erdmann.

With her expertise, the director of the Institute of Cardiogenetics at the University of Lübeck now strengthens the Leopoldina, which is a classic learned society with its approximately 1,600 members from almost all scientific fields. The proportion of female scientists among its members has risen from seven to 15 per cent in the past ten years. “Being accepted into the Leopoldina is a success and a great honour for me in two ways,” explains Prof. Erdmann. “On the one hand, I am pleased that my scientific work has been recognised by the Academy. Here I would like to thank my staff in particular, as well as the national and international cooperation partners of the past 15 years, without whom this success would not have been possible. On the other hand, admission to the Leopoldina rewards the efforts of the past years and perhaps strengthens more young women and people with physical limitations to embark on the fulfilling, but sometimes also rocky path of an academic career. I would be extremely pleased about that.”

The Academy’s tasks include representing German science abroad and advising politicians and the public. The Leopoldina unites researchers with special expertise in their respective fields. The approximately 1,600 Academy members come from over 30 countries. Every year, about 50 scientists are elected to the Academy for life in a multi-stage selection process. Admission follows a nomination by Academy members, which is followed by a multi-stage selection process by the Section, the Class and the Presidium.

Since the Academy was founded in 1652, more than 7,000 personalities have been admitted to its ranks. These have included Marie Curie, Charles Darwin, Albert Einstein, Johann Wolfgang von Goethe, Alexander von Humboldt, Justus von Liebig and Max Planck.

Congrats from CureCMD

A special pleasure was the congratulations from CureCMD.

Cure CMD was founded in 2008 by three parents whose children were affected by Congenital Muscular Dystrophy. Through close collaboration with researchers, clinicians, families, and generous supporters, Cure CMD has achieved significant impact in its first decade as a nonprofit organization:

  • Launched two clinical trials 

  • Completed a five year natural history study with the NIH to identify clinical trial endpoints

  • Grew the Congenital Muscle Disease International Registry (CMDIR) to more than 3,000 registrants worldwide

  • Co-Funded over $3 million in research grants

The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets

Nording H, Baron L, Haberthür D, Emschermann F, Mezger M, Sauter M, Sauter R, Patzelt J, Knoepp K, Nording A, Meusel M, Meyer-Saraei R, Hlushchuk R, Sedding D, Borst O, Eitel I, Karsten CM, Feil R, Pichler B, Erdmann J, Verschoor A, Chavakis E, Chavakis T, von Hundelshausen P, Köhl J, Gawaz M, Langer HF.

Nat Commun. 2021 Jun 7;12(1):3352. doi: 10.1038/s41467-021-23499-w.

https://pubmed.ncbi.nlm.nih.gov/34099640/

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.

Aragam KA, Jiang T, Anuj Goel, Stavroula Kanoni, Brooke N Wolford, Elle M Weeks, Minxian Wang, George Hindy, Wei Zhou, Christopher Grace, Carolina Roselli, Nicholas A Marston, Frederick K Kamanu, Ida Surakka, Loreto Munoz Venegas, Paul Sherliker, Satoshi Koyama, Kazuyoshi Ishigaki, Bjorn O Asvold, Michael R Brown, Ben Brumpton, Paul S de Vries, Olga Giannakopoulou, Panagiota Giardoglou, Daniel F Gudbjartsson, Ulrich Guldener, Syed M. Ijlal Haider, Anna Helgadottir, Maysson Ibrahim, Adnan Kastrati, Thorsten Kessler, Ling Li, Lijiang Ma, Thomas Meitinger, Soren Mucha, Matthias Munz, Federico Murgia, Jonas B Nielsen, Markus M Nothen, Shichao Pang, Tobias Reinberger, Gudmar Thorleifsson, Moritz von Scheidt, Jacob K Ulirsch, EPIC-CVD Consortium, Biobank Japan, David O Arnar, Deepak S Atri, Noel P Burtt, Maria C Costanzo, Jason Flannick, Rajat M Gupta, Kaoru Ito, Dong-Keun Jang, Yoichiro Kamatani, Amit V Khera, Issei Komuro, Iftikhar J Kullo, Luca A Lotta, Christopher P Nelson, Robert Roberts, Gudmundur Thorgeirsson, Unnur Thorsteinsdottir, Thomas R Webb, Aris Baras, Johan LM Bjorkegren, Eric Boerwinkle, George Dedoussis, Hilma Holm, Kristian Hveem, Olle Melander, Alanna C Morrison, Marju Orho-Melander, Loukianos S Rallidis, Arno Ruusalepp, Marc S Sabatine, Kari Stefansson, Pierre Zalloua, Patrick T Ellinor, Martin Farrall, John Danesh, Christian T Ruff, Hilary K Finucane, Jemma C Hopewell, Robert Clarke, Jeanette Erdmann, Nilesh J Samani, Heribert Schunkert, Hugh Watkins, Cristen J Willer, Panos Deloukas, Sekar Kathiresan, Adam S Butterworth, on behalf of the CARDIoGRAMplusC4D Consortium

https://doi.org/10.1101/2021.05.24.21257377

Identification of two novel bullous pemphigoid- associated alleles, HLA-DQA1*05:05 and -DRB1*07:01, in Germans

Schwarm C, Gola D, Holtsche MM, Dieterich A, Bhandari A, Freitag M, Nürnberg P, Toliat M, Lieb W, Wittig M, Franke A, Worm M, Sticherling M, Ehrchen J, Günther C, Gläser R, Peitsch WK, Sárdy M, Eming R, Hertl M, Benoit S, Goebeler M, Pföhler C, Kunz M, Kreuter A, van Beek N, Erdmann J, Busch H, Zillikens D, Sadik CD, Hirose M, König IR, Schmidt E, Ibrahim SM; German AIBD Study Group.

Orphanet J Rare Dis. 2021 May 19;16(1):228. doi: 10.1186/s13023-021-01863-9.

https://pubmed.ncbi.nlm.nih.gov/34011352/

Science on Friday

Atherosclerosis: What’s new in the DZHK?
Freitag, 28. Mai 2021
Chairs: C. Weber, E. Lutgens, J. Erdmann


The endothelial cell S-sulfhydrome and atherosclerosis

Ingrid Fleming, Klinikum der Johann Wolfgang Goethe-Universität

Stress promotes atherosclerosis

Hendrik Sager, Deutsches Herzzentrum München

CD8+ T cells in atherosclerosis

Alma Zernecke-Madsen, Universitätsklinikum Würzburg

Scroll to Top